Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14

被引:29
|
作者
Bhattacharyya, Bula J. [1 ]
Wilson, Scott M. [2 ]
Jung, Hosung [1 ]
Miller, Richard J. [1 ]
机构
[1] Northwestern Univ, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA
[2] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2012年 / 302卷 / 04期
基金
美国国家卫生研究院;
关键词
neuromuscular transmission; vesicle cycling; ubiquitin-proteasome system; ataxic mice; MOTOR-NERVE TERMINALS; FROG NEUROMUSCULAR-JUNCTION; UBIQUITIN-PROTEASOME SYSTEM; SYNAPTIC VESICLE POOLS; LONG-TERM FACILITATION; TRANSMITTER RELEASE; REPETITIVE STIMULATION; ATAXIA MICE; DEPENDENT UBIQUITINATION; ACETYLCHOLINE-RECEPTORS;
D O I
10.1152/ajpcell.00326.2010
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Bhattacharyya BJ, Wilson SM, Jung H, Miller RJ. Altered neurotransmitter release machinery in mice deficient for the deubiquitinating enzyme Usp14. Am J Physiol Cell Physiol 302: C698-C708, 2012. First published November 9, 2011; doi:10.1152/ajpcell.00326.2010.-Homozygous ataxic mice (ax(J)) express reduced levels of the deubiquitinating enzyme Usp14. They develop severe tremors by 2-3 wk of age, followed by hindlimb paralysis, and death by 6-8 wk. While changes in the ubiquitin proteasome system often result in the accumulation of ubiquitin protein aggregates and neuronal loss, these pathological markers are not observed in the ax(J) mice. Instead, defects in neurotransmission were observed in both the central and peripheral nervous systems of ax(J) mice. We have now identified several new alterations in peripheral neurotransmission in the ax(J) mice. Using the two-microelectrode voltage clamp technique on diaphragm muscles of axJ mice, we observed that under normal neurotransmitter release conditions axJ mice lacked paired-pulse facilitation and exhibited a frequency-dependent increase in rundown of the end plate current at high-frequency stimulation (HFS). Combined electrophysiology and styryl dye staining revealed a significant reduction in quantal content during the initial and plateau portions of the HFS train. In addition, uptake of styryl dyes (FM dye) during HFS demonstrated that the size of the readily releasable vesicle pool was significantly reduced. Destaining rates for styryl dyes suggested that ax(J) neuromuscular junctions are unable to mobilize a sufficient number of vesicles during times of intense activity. These results imply that ax(J) nerve terminals are unable to recruit a sufficient number of vesicles to keep pace with physiological rates of transmitter release. Therefore, ubiquitination of synaptic proteins appears to play an important role in the normal operation of the neurotransmitter release machinery and in regulating the size of pools of synaptic vesicles.
引用
收藏
页码:C698 / C708
页数:11
相关论文
共 50 条
  • [31] Distinct effects of ubiquitin overexpression on NMJ structure and motor performance in mice expressing catalytically inactive USP14
    Vaden, Jada H.
    Watson, Jennifer A.
    Howard, Alan D.
    Chen, Ping-Chung
    Wilson, Julie A.
    Wilson, Scott M.
    Frontiers in Molecular Neuroscience, 2015, 8
  • [32] Synaptic defects in ataxia mice result from a mutation in Usp14, encoding a ubiquitin-specific protease
    Wilson, SM
    Bhattacharyya, B
    Rachel, RA
    Coppola, V
    Tessarollo, L
    Householder, DB
    Fletcher, CF
    Miller, RJ
    Copeland, NG
    Jenkins, NA
    NATURE GENETICS, 2002, 32 (03) : 420 - 425
  • [33] ALTERED ACETYLCHOLINE RELEASE IN THE HIPPOCAMPUS OF DYSTROPHIN-DEFICIENT MICE
    Parames, S. F.
    Coletta-Yudice, E. D.
    Nogueira, F. M.
    De Sousa, M. B. Nering
    Hayashi, M. A.
    Lima-Landman, M. T. R.
    Lapa, A. J.
    Souccar, C.
    NEUROSCIENCE, 2014, 269 : 173 - 183
  • [34] Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency
    Ma, Yu-Shui
    Wang, Xiao-Feng
    Yu, Fei
    Wu, Ting-Miao
    Liu, Ji-Bin
    Zhang, Yun-Jie
    Xia, Qing
    Jiang, Zong-Yuan
    Lin, Qin-Lu
    Fu, Da
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2020, 5 (01)
  • [35] Inhibition of USP14 and UCH37 deubiquitinating activity by b-AP15 as a potential therapy for tumors with p53 deficiency
    Yu-Shui Ma
    Xiao-Feng Wang
    Fei Yu
    Ting-Miao Wu
    Ji-Bin Liu
    Yun-Jie Zhang
    Qing Xia
    Zong-Yuan Jiang
    Qin-Lu Lin
    Da Fu
    Signal Transduction and Targeted Therapy, 5
  • [36] Inhibition of Parkin-opposing Deubiquitination Enzyme USP14 as a therapeutic approach to enhance clearance of misfolded proteins in PD
    Ziviani, Elena
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S41 - S41
  • [37] Investigating bAP15, a new inhibitor of UCHL5/USP14 deubiquitinating enzymes, as a potential treatment for chondrosarcoma: A comprehensive in vivo and in vitro study
    Kuo, Kuan-Lin
    Hsu, Fu-Shun
    Chang, Shang-Jen
    Liao, Shih-Ming
    Lin, Wei-Chou
    Ke, Tzt-Yao
    Liu, Tzu-Ting
    Huang, Kuo-Yuan
    CANCER RESEARCH, 2024, 84 (06)
  • [38] Overexpression of USP14 Protease Reduces I-κB Protein Levels and Increases Cytokine Release in Lung Epithelial Cells
    Mialki, Rachel K.
    Zhao, Jing
    Wei, Jianxin
    Mallampalli, Daniel F.
    Zhao, Yutong
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2013, 288 (22) : 15437 - 15441
  • [39] Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
    Paulus, A.
    Akhtar, S.
    Caulfield, T. R.
    Samuel, K.
    Yousaf, H.
    Bashir, Y.
    Paulus, S. M.
    Tran, D.
    Hudec, R.
    Cogen, D.
    Jiang, J.
    Edenfield, B.
    Novak, A.
    Ansell, S. M.
    Witzig, T.
    Martin, P.
    Coleman, M.
    Roy, V.
    Ailawadhi, S.
    Chitta, K.
    Linder, S.
    Chanan-Khan, A.
    BLOOD CANCER JOURNAL, 2016, 6 : e492 - e492
  • [40] Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells
    A Paulus
    S Akhtar
    T R Caulfield
    K Samuel
    H Yousaf
    Y Bashir
    S M Paulus
    D Tran
    R Hudec
    D Cogen
    J Jiang
    B Edenfield
    A Novak
    S M Ansell
    T Witzig
    P Martin
    M Coleman
    V Roy
    S Ailawadhi
    K Chitta
    S Linder
    A Chanan-Khan
    Blood Cancer Journal, 2016, 6 : e492 - e492